Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti- inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes

Psychiatry Research

Volumn 85, Issue 3, 1999, Pages 293-303

  Song, Cai ^a,b   Kenis, Gunter ^c   Van Gastel, Ann ^a   Bosmans, Eugène ^c   Lin, Aihua ^a,d   De Jong, Raf ^c   Neels, Hugo ^e   Scharpé, Simon ^d   Janca, Aleksandar ^f   Yasukawa, Kiyoshi ^g   Maes, Michael ^a,h  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

^b CARLETON UNIVERSITY   (Canada)

^c Eurogenetics   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e Laboratory of Clinical Biology   (Belgium)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g TOSOH CORPORATION   (Japan)

^h VANDERBILT UNIVERSITY   (United States)

Author keywords

Anxiety; Cytokines; Glycoprotein 130; Interleukin 6; T Lymphocytes

Indexed keywords

CD14 ANTIGEN; CD8 ANTIGEN; CYTOKINE; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6 RECEPTOR; PROTEIN; SEX HORMONE;

ADULT; ARTICLE; CLARA CELL; CLINICAL ARTICLE; CONTRACEPTION; FEMALE; HORMONE ACTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNE RESPONSE; INFLAMMATION; MALE; MENTAL STRESS; MONOCYTE; PRIORITY JOURNAL; SEX DIFFERENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD; ANXIETY; CYTOKINES; FEMALE; GLYCOPROTEINS; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; MALE; MEMBRANE PROTEINS; MONOCYTES; NEUROIMMUNOMODULATION; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; STRESS, PSYCHOLOGICAL; T-LYMPHOCYTES;

EID: 0033594109     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(99)00012-8     Document Type: Article

References (69)

1. Aukrust P., Froland S.S., Liabakk N.B., Muller F., Nordoy I., Haug C., Espevik T. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood. 84:1994;2136-2143.
2. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Yok B., Berger M. Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. Federation of European Biochemical Societies. 285:1991;111-114.
3. Benigni F., Fantuzzi G., Sacco S., Sironi M., Pozzi P., Dinarello C.A., Sipe J.D., Poli V., Cappelletti M. Six different cytokines that share GP 130 as receptor subunit. Blood. 87:1996;1851-1854.
4. Black P.H. Immune system-central nervous system interactions: effect and immunomodulatory consequences of immune system mediators on the brain. Antimicrobial Agents and Chemotherapy. 38:1994;7-12.
5. Boyum A., Wiik P., Gustavsson E., Veiby O.P., Reseland J., Haugen A.H., Opstad P.K. The effect of strenuous exercise, calorie deficiency and sleep deprivation on white blood cells, plasma immunoglobins and cytokines. Scandinavian Journal of Immunology. 43:1996;228-235.
6. Brosschot J.F., Benschop R.J., Godaert G.L., de Smet M.B., Olff M., Heijnen C.J., Ballieux R.E. Effects of experimental psychological stress on distribution and function of peripheral blood cells. Psychosomatic Medicine. 54:1992;394-406.
7. Brown, G.W., Harris, T.O., 1989. Depression. In: Brown, G.W., Harris T.O. (Eds.), Life Events and Illness. Guilford Press, New York, pp. 49-94.
8. Cavaillon, J.M., 1996. Les Cytokines, Masson. Paris.
9. Chiappelli F., Manfrini E., Franceschi C., Cossarizza A., Black K.L. Steroid regulation of cytokines. Annals of the New York Academy of Sciences. 746:1994;204-215.
10. Cid M.S., Kleinman H.K., Grant D.S., Schnaper H.W., Fauci A.S., Hoffman G.S. Estradiol enhances leukocyte binding to tumour necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule. Journal of Clinical Investigation. 93:1994;17-25.
11. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. Journal of Health and Social Behavior. 24:1983;385-396.
12. Cosman D., Lyman S.D., Idzerda R.L., Beckman M.P., Park L.S., Goodwin R.G., March C.J. A new cytokine receptor superfamily. Trends in Biochemical Sciences. 15:1990;265-269.
13. Croiset G., Heijnen C.J., Veldhuis H.D., de Wied D., Ballieux R.E. Modulation of the immune response by emotional stress. Life Sciences. 40:1987;775-782.
14. Dayer J.M., Burger D. Interleukin-1, tumour necrosis factor and their specific inhibitors. European Cytokine Network. 5:1994;563-571.
15. De Souza E.B., Holaday J.W. Stress, neuroendocrine, and immune relationships. Psychopharmacology Bulletin. 25:1989;299-305.
16. Dierynck I., Bernard A., Roels H., De Ley M. Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC16. American Journal of Respiratory Cell and Molecular Biology. 12:1995;205-210.
17. Dower S.K. Cytokine receptor families. Advances in Second Messenger Phosphoprotein Research. 28:1993;19-25.
18. Dugue B., Leppanen E.A., Teppo A.M., Fyhrquist F., Grasbeck R. Effects of psychological stress on plasma interleukins-1 beta and 6, C-reactive protein, tumour necrosis factor alpha, anti-diuretic hormone and serum cortisol. Scandinavian Journal of Clinical and Laboratory Investigation. 53:1993;555-561.
19. Frey E.A., Miller D.S., Jahr T.G., Sundan A., Bazil V., Espevik T., Finlay B.B., Wright S.D. Soluble CD14 participates in the response of cells to lipopolysaccharide. Journal of Experimental Medicine. 176:1992;1665-1671.
20. Fuchs D., Samsonov M., Tilz G.P., Reibnegger G., Belenkov J.N., Nassonov E.L., Wachter H. Stimulated cellular immune system in patients with congestive heart failure. European Journal of Clinical Chemistry and Clinical Biochemistry. 31:1993;111-114.
21. Gerritsen W., Heijnen C.L., Wiegant V.M., Bermond B., Frijda N.H. Experimental social fear - immunological, hormonal, and autonomic concomitants. Psychosomatic Medicine. 58:1996;273-286.
22. Gesner M., Di John D., Krasinski K., Borkowsky W. Increased soluble CD8 in human immunodeficiency virus 1-infection children in the first month and year of life. Pediatric Infectious Disease Journal. 13:1994;896-898.
23. Glaser R., Kennedy S., Lafuse W.P., Bonneau R.H., Speicher C., Hillhouse J., Kiecolt-Glaser J.K. Psychological stress-induced modulation of interleukin 2 receptor gene expression and interleukin 2 production in peripheral blood leukocytes. Archives of General Psychiatry. 47:1990;707-712.
24. Gotlib, I.H., Cane, D.B., 1989. Self-report assessment of depression and anxiety. In: Kendall, P.C., Watson, D. (Eds.), Anxiety and Depression: Distinctive and Overlapping Features. Academic Press, San Diego, CA, pp. 131-169.
25. Griffin W.S.T., Stanley L.C., White L., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain interleukin-1 and S-100 protein immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 86:1989;7611-7615.
26. Hammerschmidt D.E., Knabe A.C., Silberstein P.T., Lamche H.R., Coppo P.A. Inhibition of granulocyte function by steroids is not limited to corticoids. Studies with sex steroids. Inflammation. 12:1988;277-284.
27. Harrington L., Affleck G., Urrows S., Tennen H., Higgings P., Zautra A., Hoffman S. Temporal covariation of soluble interleukin-2 receptor levels, daily stress, and disease activity in rheumatoid arthritis. Arthritis and Rheumatism. 36:1993;199-203.
28. Howell, D.C., 1982. Multiple comparisons among treatment means. In: Howell, D.C. (Ed.), Statistical Methods for Psychology. Duxbury Press, Boston, pp. 289-307.
29. Kim H.S., Degiannis D., Raskova J., Raska K. Cyclosporin A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: correlation with proliferative responses. Clinical Immunology and Immunopathology. 60:1991;27-39.
30. LeMay L.G., Vander A.J., Kluger M.J. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiology and Behavior. 47:1990;957-961.
31. Leonard, B.E., 1995. Stress and the immune system: immunological aspects of depressive illness. In: Leonard, B.E., Miller, K. (Eds.), Stress, the Immune System and Psychiatry. John Wiley and Sons, England, pp. 113-137.
32. Lin A., Kenis G., Bignotti S., Tura G.J., De Jong R., Bosmans E., Pioli R., Attamura C., Scharpé S., Maes M. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophrenia Research. 32:1998;9-15.
33. Lu Z.Y., Brailly H., Wijdnes J., Bataille R., Rossi J.F., Klein B. Measurement of whole body interleukin-6 production. Blood. 85:1994;3123-3131.
34. Lynch E.A., Dinarello C.A., Cannon J.G. Gender differences in IL-1 alpha, IL-1 beta receptor antagonist secretion from mononuclear cells and urinary excretion. Journal of Immunology. 153:1994;300-306.
35. Maes M., Bosmans E., Meltzer H.Y., Scharpé S., Suy E. Interleukin-1β: a putative mediator of HPA-axis hyperactivity in major depression? American Journal of Psychiatry. 150:1993;1189-1193.
36. Maes M., Scharpé S., Meltzer H.Y., Bosmans E., Suy E., Calabrese J., Cosyns P. Relationship between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Research. 49:1993;11-27.
37. Maes M., Stevens S., Scharpé S., Bosmans E., De Meyer F., D'Hondt P., Peeters D., Thompson P., Cosyns P., De Clerck L. Seasonal variation in peripheral blood leukocyte subsets and in serum interleukin-6, and soluble interleukin-2 and -6 receptor concentrations in normal volunteers. Experientia. 50:1994;821-829.
38. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders. 34:1995;301-309.
39. Maes M., Smith R., Scharpé S. The monocyte-T lymphocyte hypothesis of major depression. Psychoneuroendocrinology. 20:1995;111-116.
40. Maes M., Vandoolaeghe E., Ranjan R., Bosmans E., Bergmans R., Desnyder R. Increased serum interleukin-1-receptor-antagonist concentrations in major depression. Journal of Affective Disorders. 36:1995;29-36.
41. Maes M., Bosmans E., Ranjan R., Vandoolaeghe E., Meltzer H.Y., Bergmans R., Stans G., Desnyder R. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia-effects of antipsychotic drugs. Schizophrenia Research. 21:1996;39-50.
42. Maes M., Vandoolaeghe E., Ranjan R., Bosmans E., Van Gastel A., Bergmans R., Desnyder R. Increased serum soluble CD8 or suppressor/cytotoxic antigen concentrations in depression: suppressive effects of glucocorticoids. Biological Psychiatry. 40:1996;1273-1281.
43. Maes M., Song C., Lin A., De Jong R., van Gastel A., Kenis G., Bosmans E., De Meester I., Benoy I., Neels H., Demedts P., Janca A., Scharpé S., Smith R.S. The effect of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 10:1998;313-318.
44. Maier S.F., Watkins L.R., Fleshner M. The interface between behavior, brain and immunity. American Psychologist. 49:1994;1004-1017.
45. Matsuda T., Fukada T., Takahashi-Tezuka M., Okuyama Y., Fujitani Y., Hanazono Y., Hirai H., Hirano T. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. Journal of Biological Chemistry. 270:1995;11037-11039.
46. Murakami-Mori K., Taga T., Kishimoto T., Nakamura S. The soluble form of the IL-6 receptor (sIL-6Rá) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for IL-6Rá-induced AIDS-KS cell growth. International Immunology. 8:1996;595-602.
47. Nockher W.A., Scherberich J.E. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS. Kidney International. 48:1995;1469-11467.
48. Oesterreicher C., Pfeffel F., Petermann D., Muller C. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. Journal of Hepatology. 23:1995;396-402.
49. Rabin, B.S., Kusnecov, A., Shurin, M., Zhou, D., Rasnick, S., 1994. Mechanistic aspects of stressor-induced immune alteration. In: Glaser, R., Kiecolt-Glaser, J. (Eds.), Handbook of Human Stress and Immunity. Academic Press, San Diego, CA, pp. 23-48.
50. Relton J.K., Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischemic and excitatory neuronal damage in the rat. Brain Research Bulletin. 29:1992;243-246.
51. Rhind S.G., Shek P.N., Shinkai S., Shephard R.J. Differential expression of interleukin-2 receptor alpha and beta chains in relation to natural killer cells subsets and aerobic fitness. International Journal of Sports Medicine. 15:1994;311-318.
52. Saito T., Taga T., Miki D., Futatsugi K., Yawata H., Kishimoto T., Yasukawa K. Preparation of monoclonal antibodies against the IL-6 signal transducer, gp130, that can inhibit IL-6-mediated function. Journal of Immunological Methods. 163:1993;217-223.
53. Schulte H.M., Bamberger C.M., Elsen H., Herrmann G., Bamberger A.M., Barth J. Systemic interleukin-1-alpha and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans. European Journal of Clinical Investigation. 24:1994;773-777.
54. Schutt C., Schilling T., Grunwald U., Schonfeld W., Kruger C. Endotoxin-neutralizing capacity of soluble CD14. Research in Immunology. 143:1992;71-78.
55. Shephard R.J., Rhind S., Shek P.N. Exercise and training: influences on cytotoxicity, interleukin-1, interleukin-2 and receptor structures. International Journal of Sports Medicine. 15:1994;154-166.
56. Shintani F., Nakaki T., Kanba S., Sato K., Yagi G., Shiozawa M., Aiso S., Kato R., Asai M. involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. Journal of Neuroscience. 15:1995;1961-1970.
57. Sims J.E., Dower S.K. Interleukin-1 receptors. European Cytokine Network. 5:1994;539-546.
58. Singh V.K. Studies of neuroimmune markers in Alzheimer's disease. Molecular Neurobiology. 9:1994;73-81.
59. Sluzewska A., Rybakowski J.K., Laciak M., Mackiewicz A., Sobieska M., Wiktorowiz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Annals of the New York Academy of Sciences. 762:1995;474-476.
60. Sluzewska A., Rybakowski J., Bosmans E., Sobieska M., Berghmans R., Maes M., Wiktorowicz K. Indicators of immune activation in major depression. Psychiatry Research. 64:1996;161-167.
61. Spielberger, C.D., Edwards, C.D., Mantoun, J., Lushene, R.E., 1987. The State-Trait Inventory. NFER-Nelson, Windsor.
62. Song C., Kelly J., Leonard B.E. The effect of stressful behavioural exposure on endocrine and immune parameters in the rat. Stress Medicine. 10:1994;239-245.
63. Song C., Leonard B.E. Interleukin-2 induced changes in behaviour, neurotransmitter and immune functions in olfactory bulbectomized rats: IL-2 may be a modulator of depression in the central nervous system. NeuroImmunoModulation. 2:1995;263-273.
64. Song C., Earley B., Leonard B.E. Behavioural, neurochemical, and immunological responses to CRF administration: is CRF a mediator of stress? Annals of the New York Academy of Sciences. 771:1995;55-72.
65. Tilz G.P., Domej W., Diez-Ruiz A., Weiss G., Brezinschek R., Brezinschek H.P., Huttl E., Fuchs D. Increased immune activation during and after physical exercise. Immunobiology. 188:1993;194-202.
66. Weiss J.M., Sundar S.K., Becker K.J., Cierpial M.A. Behavioural and neural influences on cellular immune responses: effects of stress and interleukin-1. Journal of Clinical Psychiatry. 50:1989;43-55.
67. Wenisch C., Wenisch H., Parschalk B., Vanijanonta S., Burgmann H., Exner M., Zedwitz-Liebenstein K., Thalhammer F., Georgopoulos A. Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria. Clinical and Experimental Immunology. 105:1996;74-78.
68. Wicher J.T. Cytokines in diseases. Clinical Chemistry. 36:1990;1269-1281.
69. Zhang X.-G., Gu J.-J., Lu Z.-Y., Yasukawa K., Yancopoulos G.D., Turner K., Shoyab M., Taga T., Kishimoto I., Bataille R., Klein B. Ciliary neurotropic factor, interleukin-II, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. Journal of Experimental Medicine. 177:1994;1337-1342.